Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Option Assessment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5a-0501. Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Option Comparison Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5b-0501. Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Additional Information Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5c-0501. Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7a-0501. Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;-. doi: 10.1001/virtualmentor.2005.7.1.ccas7b-0501. Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501. Case and Commentary Jan 2005 An Inoperable Cancer Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13a-0501. Case and Commentary Jan 2005 An Inoperable Cancer, Option Comparison Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13b-0501. Case and Commentary Jan 2005 An Inoperable Cancer, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):68-73. doi: 10.1001/virtualmentor.2005.7.1.ccas13c-0501. State of the Art and Science Nov 2019 What’s Missing in Our Thinking About Quality of Life in VCA? Emily Herrington, PhD, MA Despite drawbacks of immunosuppression and surgery, vascularized composite allotransplants can enhance lives of patients who meet candidacy criteria and are well supported. AMA J Ethics. 2019;21(11):E968-973. doi: 10.1001/amajethics.2019.968. Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Option Assessment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5a-0501.
Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Option Comparison Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5b-0501.
Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Additional Information Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5c-0501.
Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7a-0501.
Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;-. doi: 10.1001/virtualmentor.2005.7.1.ccas7b-0501.
Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501.
Case and Commentary Jan 2005 An Inoperable Cancer Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13a-0501.
Case and Commentary Jan 2005 An Inoperable Cancer, Option Comparison Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13b-0501.
Case and Commentary Jan 2005 An Inoperable Cancer, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):68-73. doi: 10.1001/virtualmentor.2005.7.1.ccas13c-0501.
State of the Art and Science Nov 2019 What’s Missing in Our Thinking About Quality of Life in VCA? Emily Herrington, PhD, MA Despite drawbacks of immunosuppression and surgery, vascularized composite allotransplants can enhance lives of patients who meet candidacy criteria and are well supported. AMA J Ethics. 2019;21(11):E968-973. doi: 10.1001/amajethics.2019.968.